| Ytd | 14.42% | |
| 1y | 4.67% |
| Open | 48.62 | Prev Close | 48.49 | Low | 48.31 | High | 49.15 | Mkt Cap | 2.84B |
| Vol | 429.90K | Avg Vol | 446.16K | EPS | 2.76 | P/E | 17.54 | Forward P/E | 11.12 |
| Beta | 0.64 | Short Ratio | 4.17 | Inst. Own | 102.37% | Dividend | 1.16 | Div Yield | 2.37 |
| Ex Div Date | 10-01 | Earning | 09-08 | 50-d Avg | 48.41 | 200-d Avg | 44.07 | 1yr Est | 55.93 |
UniFirst (NYSE: UNF - Get Free Report) and ABM Industries (NYSE: ABM - Get Free Report) are both mid
Truist Securities analyst Jasper Bibb maintains ABM Indus (NYSE:ABM) with a Hold and raises the p
Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed u
UBS analyst Joshua Chan maintains ABM Indus (NYSE:ABM) with a Neutral and raises the price target
ABM beats Q3 estimates, posts record revenue, narrows FY26 EPS outlook; analysts raise price targets
Baird analyst Andrew Wittmann maintains ABM Indus (NYSE:ABM) with a Neutral and raises the price
Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHY
Freedom Capital Markets analyst David Silver maintains ABM Indus (NYSE:ABM) with a Buy and raises
ABM stock jumps 7% after beating Q3 2026 earnings estimates, boosted by semiconductor and data cente
U.S. stocks fell Tuesday as health care lagged, while energy gained. ABM beat estimates; oil rose, a
ABM Indus (NYSE:ABM) reported third-quarter financial results on Tuesday. The transcript from the co
ABM Indus (NYSE:ABM) reported quarterly earnings of $1.04 per share which beat the analyst consensus
Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey’s
U.S. stocks fell as strong jobs data boosted Fed rate-hike odds. Fear & Greed Index declined to